when lidocaine is used in the treatment of ventricular fibrillation, the recommended dose is:

What is the initial dose of lidocaine given for cardiac arrest?

Doses Range from 0.5 to 0.75 mg/kg and up to 1 to 1.5mg/kg. Repeat 0.5 to 0.75 mg/kg every 5-10 minutes with maximum total dose of 3 mg/kg. Maintenance infusion: 1 to 4 mg/min (30-50 mcg/kg/min) Discontinue a lidocaine infusion immediately if signs of toxicity develop.

How is lidocaine used to treat ventricular tachycardia?

Aug 05, 2020 · Lidocaine Dosage: When used to treat cardiac arrest from VT/VF, the initial dose should be 1-1.5 mg/kg IV/IO. For refractory VF, an additional 0.5-0.75 mg/kg IV push may be given, then repeated every 5-10 minutes, with a max of 3 doses or a total of 3 mg/kg.

What is the initial dose for cardiac arrest from ventricular fibrillation?

Jun 01, 2016 · Lidocaine Dosage. Cardiac Arrest from VT / VT: 1 – 1.5 mg/kg via IV/IO. Refractory VF: Additional 0.5 – 0.75 mg/kg via IV/IO; Repeat every 5 – 10 minutes for maximum of 3 doses, or 3 mg/kg. Stable VT: 0.5 – 0.75 mg/kg up to 1.5 mg/kg; Repeat in 0.5 – 0.75 mg/kg doses to maximum of 3 mg/kg.

What is lidocaine for ACLS exam?

Adult Dosage for Lidocaine: Dosage for cardiac arrest from ventricular fibrillation or pulseless ventricular tachycardia: Initial dose is 1 to 1.5 mg/kg IV or IO. Can also be delivered via endotracheal tube. Dosage for refractory ventricular fibrillation: An additional .5 to .75 mg/kg may be given via IV push.

The Effects of Lidocaine

Lidocaine causes negative inotropic effects and antiarrhythmic actions in the heart that weaken the force of muscular contractions. Lidocaine can calm erratic and uncoordinated electro-myocardial activity.

Lidocaine Precautions & Contraindications

Lidocaine should not be used as a prophylactic treatment in acute myocardial infarction.

Adult Dosage for Lidocaine

Dosage for cardiac arrest from ventricular fibrillation or pulseless ventricular tachycardia:

Usual Adult Dose for Ventricular Fibrillation

Initial dose: 50 to 100 mg IV bolus once over 2 to 3 minutes; may repeat after 5 minutes if necessary not to exceed up to 300 mg in a 1-hour period#N#Following bolus administration: 1 to 4 mg/min continuous IV infusion#N#Comments:#N#-Patients should be under constant ECG monitoring during administration of this drug.#N#-Sufficient time should be allowed to enable a slow circulation to carry this drug to the site of action.#N#-The rate of the IV infusion should be reassessed as soon as the patient's basic cardiac rhythm appears stable or at the earliest signs of toxicity.#N#Uses: For the acute management of ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery; and for life-threatening arrhythmias which are ventricular in origin, such as those that occur during acute myocardial infarction#N#The American Heart Association (AHA) recommends:#N#IV:#N#-Initial dose: 1 to 1.5 mg/kg IV bolus once; may repeat if necessary at a dose of 0.5 to 0.75 mg/kg IV every 5 to 10 minutes up to a maximum cumulative dose of 3 mg/kg#N#-Following bolus administration: 1 to 4 mg/min continuous IV infusion (30 to 50 mcg/kg/min)#N#Endotracheal: May be administered endotracheally (bolus dose only) if IV access unavailable at a dose of 2 to 2.5 times the IV dose diluted in 5 to 10 mL NS or distilled water#N#Uses: For the treatment of ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT) unresponsive to CPR, defibrillation, and vasopressor therapy as an alternative to amiodarone.

Usual Adult Dose for Ventricular Tachycardia

Initial dose: 50 to 100 mg IV bolus once over 2 to 3 minutes; may repeat after 5 minutes if necessary not to exceed up to 300 mg in a 1-hour period#N#Following bolus administration: 1 to 4 mg/min continuous IV infusion#N#Comments:#N#-Patients should be under constant ECG monitoring during administration of this drug.#N#-Sufficient time should be allowed to enable a slow circulation to carry this drug to the site of action.#N#-The rate of the IV infusion should be reassessed as soon as the patient's basic cardiac rhythm appears stable or at the earliest signs of toxicity.#N#Uses: For the acute management of ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery; and for life-threatening arrhythmias which are ventricular in origin, such as those that occur during acute myocardial infarction#N#The American Heart Association (AHA) recommends:#N#IV:#N#-Initial dose: 1 to 1.5 mg/kg IV bolus once; may repeat if necessary at a dose of 0.5 to 0.75 mg/kg IV every 5 to 10 minutes up to a maximum cumulative dose of 3 mg/kg#N#-Following bolus administration: 1 to 4 mg/min continuous IV infusion (30 to 50 mcg/kg/min)#N#Endotracheal: May be administered endotracheally (bolus dose only) if IV access unavailable at a dose of 2 to 2.5 times the IV dose diluted in 5 to 10 mL NS or distilled water#N#Uses: For the treatment of ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT) unresponsive to CPR, defibrillation, and vasopressor therapy as an alternative to amiodarone.

Usual Adult Dose for Cardiac Arrhythmia

Initial dose: 50 to 100 mg IV bolus once over 2 to 3 minutes; may repeat after 5 minutes if necessary not to exceed up to 300 mg in a 1-hour period#N#Following bolus administration: 1 to 4 mg/min continuous IV infusion#N#Comments:#N#-Patients should be under constant ECG monitoring during administration of this drug.#N#-Sufficient time should be allowed to enable a slow circulation to carry this drug to the site of action.#N#-The rate of the IV infusion should be reassessed as soon as the patient's basic cardiac rhythm appears stable or at the earliest signs of toxicity.#N#Uses: For the acute management of ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery; and for life-threatening arrhythmias which are ventricular in origin, such as those that occur during acute myocardial infarction#N#The American Heart Association (AHA) recommends:#N#IV:#N#-Initial dose: 1 to 1.5 mg/kg IV bolus once; may repeat if necessary at a dose of 0.5 to 0.75 mg/kg IV every 5 to 10 minutes up to a maximum cumulative dose of 3 mg/kg#N#-Following bolus administration: 1 to 4 mg/min continuous IV infusion (30 to 50 mcg/kg/min)#N#Endotracheal: May be administered endotracheally (bolus dose only) if IV access unavailable at a dose of 2 to 2.5 times the IV dose diluted in 5 to 10 mL NS or distilled water#N#Uses: For the treatment of ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT) unresponsive to CPR, defibrillation, and vasopressor therapy as an alternative to amiodarone.

Usual Adult Dose for Anesthesia

Local Injectable Anesthesia:#N#-Maximum individual dose: 4 mg/kg (IV regional anesthesia); 4.5 mg/kg (infiltration)#N#-Maximum total dose: 300 mg#N#Comments:#N#-The manufacturer product information should be consulted.#N#-Dose varies with procedure, depth of anesthesia and degree of muscle relaxation needed, duration of anesthesia required, and physical condition of patient.#N#-For continuous epidural or caudal anesthesia, the maximum recommended dose should not be administered at intervals of less than 90 minutes.#N#-The maximum recommended dose per 90-minute period for paracervical block is 200 mg total.#N#-In all cases the lowest effective dose that will produce the desired result should be used.#N#Use: For the production of local or regional anesthesia by infiltration techniques such as percutaneous injection and IV regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Usual Pediatric Dose for Ventricular Fibrillation

The manufacturer gives no specific dosing instructions.#N#The AHA recommends:#N#IV:#N#-Initial dose: 1 mg/kg IV or intraosseous once#N#-Maintenance infusion: 20 to 50 mcg/kg/min IV#N#Endotracheal: May be administered endotracheally (bolus dose only) if IV or intraosseous access unavailable at a dose of 2 to 3 times the dose (2 to 3 mg/kg) followed by a flush with at least 5 mL of NS and 5 consecutive positive-pressure ventilations#N#Use: For use in shock-refractory VF or pVT after resuscitation from cardiac arrest in infants and children.

Usual Pediatric Dose for Ventricular Tachycardia

The manufacturer gives no specific dosing instructions.#N#The AHA recommends:#N#IV:#N#-Initial dose: 1 mg/kg IV or intraosseous once#N#-Maintenance infusion: 20 to 50 mcg/kg/min IV#N#Endotracheal: May be administered endotracheally (bolus dose only) if IV or intraosseous access unavailable at a dose of 2 to 3 times the dose (2 to 3 mg/kg) followed by a flush with at least 5 mL of NS and 5 consecutive positive-pressure ventilations#N#Use: For use in shock-refractory VF or pVT after resuscitation from cardiac arrest in infants and children.

Usual Pediatric Dose for Anesthesia

3 years or older with normal lean body mass and normal body development: Maximum dose based on patient's age and weight#N#Comments:#N#-The manufacturer product information should be consulted.#N#-Dose varies with procedure, depth of anesthesia and degree of muscle relaxation needed, duration of anesthesia required, and physical condition of patient.#N#-In all cases the lowest effective dose that will produce the desired result should be used.#N#Use: For the production of local or regional anesthesia by infiltration techniques such as percutaneous injection and IV regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Description

Treatment

Medical Uses

Side Effects

Interactions

Toxicity

Contraindications

Pharmacology

Administration

Adverse Effects